Your browser doesn't support javascript.
loading
A phase 1, randomized study to assess the pharmacokinetic comparability of siltuximab derived from two different cell lines in healthy subjects.
Xu, Chao; Han, Chao; Marini, Joseph; Ford, Joyce; Marciniak, Stanley; Lopez, Manny; Frederick, Bart; de Vries, Dick; Bandekar, Rajesh; Davis, Hugh M; Zhou, Honghui; Puchalski, Thomas A.
Afiliação
  • Xu C; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Han C; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Marini J; Janssen Research & Development, LLC, Radnor, PA, USA.
  • Ford J; Janssen Research & Development, LLC, Radnor, PA, USA.
  • Marciniak S; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Lopez M; Janssen Research & Development, LLC, Malvern, PA, USA.
  • Frederick B; Janssen Research & Development, LLC, Spring House, PA, USA.
  • de Vries D; Janssen Biologics Europe, Leiden, The Netherlands.
  • Bandekar R; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Davis HM; Janssen Research & Development, LLC, Radnor, PA, USA.
  • Zhou H; Janssen Research & Development, LLC, Spring House, PA, USA.
  • Puchalski TA; Janssen Research & Development, LLC, Spring House, PA, USA.
Clin Pharmacol Drug Dev ; 3(4): 328-34, 2014 07.
Article em En | MEDLINE | ID: mdl-27128840

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article